🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of unknown origin.

Several professionals said the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the service has removed violative content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive reviews and detailed guides for mixing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Product Information and Pricing

Inside these groups, posts show dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious medical dangers”.